文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

920家德国医院收治的10021例COVID-19住院患者的病例特征、资源使用与结局:一项观察性研究

Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study.
PubMed 文献 · Lancet Respir Med · 2020-07-28
一句话结论德国920家医院10021例COVID-19住院患者中,17%接受机械通气,总住院死亡率22%,通气患者死亡率53%,需透析的通气患者死亡率73%。

该观察性研究基于德国地方医保基金理赔数据分析2020年2月26日至4月19日住院且住院过程完整(出院或院内死亡)的成年COVID-19确诊患者,共纳入10021例、来自920家医院。17%(1727例)接受机械通气,通气患者以男性为主(男性通气概率22% vs 女性12%),最常见合并症为高血压(56%)、糖尿病(28%)、心律失常(27%)、肾衰竭(23%)。总住院死亡率22%,未通气患者16%、通气患者53%;通气患者中需透析者死亡率73%;通气患者死亡率随年龄升高,18-59岁28%,≥80岁72%。作者结论认为在医疗资源未被挤兑的德国体系中,机械通气患者死亡率仍高,尤其是≥80岁及需透析者,而<60岁者明显较低。

要点

  • 总住院死亡率22%(2229/10021),未通气患者16%(1323/8294)vs 通气患者53%(906/1727)。
  • 通气患者中需透析者住院死亡率73%(342/469),所有患者中需透析者占6%(599/10021)。
  • 通气患者住院死亡率随年龄升高:18-59岁28%(117/422),≥80岁72%(280/388)。
  • 通气概率男性22%(1147/5199)vs 女性12%(580/4822),通气组男性约为女性两倍。
  • 通气患者平均通气时间13.5天(SD 12.1);无通气患者Charlson合并症指数为0者39%(3237/8294),通气患者仅22%(374/1727)。

适用人群与场景

  • 2020年2月26日至4月19日在德国住院、确诊COVID-19的成年患者,且住院过程完整(出院或院内死亡)者纳入研究队列。
  • 数据来源为德国地方医保基金理赔数据,覆盖920家不同医院。
  • 患者按是否接受任何形式的机械通气分组。

研究设计与关键结果

  • 研究类型为观察性研究,基于德国地方医保基金理赔数据,纳入10021例住院COVID-19成年患者,来自920家医院,按是否接受机械通气分组。
  • 1727例(17%)接受机械通气;通气患者中18-59岁422例(24%)、60-69岁382例(22%)、70-79岁535例(31%)、≥80岁388例(23%);中位年龄72岁(IQR 57-82)。
  • 通气概率女性12%(580/4822)、男性22%(1147/5199);未通气组男女比例相等,通气组男性为女性两倍。
  • 最常见合并症:高血压5575/10021(56%)、糖尿病2791/10021(28%)、心律失常2699/10021(27%)、肾衰竭2287/10021(23%)、心力衰竭1963/10021(20%)、慢性肺病1358/10021(14%)。
  • 需透析者占全部患者6%(599/10021),占通气患者27%(469/1727);通气患者平均通气时间13.5天(SD 12.1)。
  • Charlson合并症指数为0者:未通气患者39%(3237/8294)vs 通气患者22%(374/1727)。
  • 住院死亡率:总体22%(2229/10021);未通气16%(1323/8294)vs 通气53%(906/1727);通气患者中仅无创通气45%(65/145)、无创通气失败50%(70/141)、有创机械通气53%(696/1318)。
  • 通气患者中需透析者住院死亡率73%(342/469);通气患者住院死亡率随年龄从18-59岁28%(117/422)升至≥80岁72%(280/388)。

证据类型、等级与局限

  • 证据类型:观察性研究(基于德国地方医保基金理赔数据)。
  • 资金:无。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,在医疗资源未被COVID-19大流行挤兑的德国医疗体系中,接受机械通气患者的死亡率仍高,尤其是≥80岁及需透析者,而<60岁者明显较低。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: Background Nationwide, unbiased, and unselected data of hospitalised patients with COVID-19 are scarce. Our aim was to provide a detailed account of case characteristics, resource use, and outcomes of hospitalised patients with COVID-19 in Germany, where the health-care system has not been overwhelmed by the pandemic.

METHODS: In this observational study, adult patients with a confirmed COVID-19 diagnosis, who were admitted to hospital in Germany between Feb 26 and April 19, 2020, and for whom a complete hospital course was available (ie, the patient was discharged or died in hospital) were included in the study cohort. Claims data from the German Local Health Care Funds were analysed. The data set included detailed information on patient characteristics, duration of hospital stay, type and duration of ventilation, and survival status. Patients with adjacent completed hospital stays were grouped into one case. Patients were grouped according to whether or not they had received any form of mechanical ventilation. To account for comorbidities, we used the Charlson comorbidity index.

FINDINGS: Of 10 021 hospitalised patients being treated in 920 different hospitals, 1727 (17%) received mechanical ventilation (of whom 422 [24%] were aged 18-59 years, 382 [22%] were aged 60-69 years, 535 [31%] were aged 70-79 years, and 388 [23%] were aged ≥80 years). The median age was 72 years (IQR 57-82). Men and women were equally represented in the non-ventilated group, whereas twice as many men than women were in the ventilated group. The likelihood of being ventilated was 12% for women (580 of 4822) and 22% for men (1147 of 5199). The most common comorbidities were hypertension (5575 [56%] of 10 021), diabetes (2791 [28%]), cardiac arrhythmia (2699 [27%]), renal failure (2287 [23%]), heart failure (1963 [20%]), and chronic pulmonary disease (1358 [14%]). Dialysis was required in 599 (6%) of all patients and in 469 (27%) of 1727 ventilated patients. The Charlson comorbidity index was 0 for 3237 (39%) of 8294 patients without ventilation, but only 374 (22%) of 1727 ventilated patients. The mean duration of ventilation was 13·5 days (SD 12·1). In-hospital mortality was 22% overall (2229 of 10 021), with wide variation between patients without ventilation (1323 [16%] of 8294) and with ventilation (906 [53%] of 1727; 65 [45%] of 145 for non-invasive ventilation only, 70 [50%] of 141 for non-invasive ventilation failure, and 696 [53%] of 1318 for invasive mechanical ventilation). In-hospital mortality in ventilated patients requiring dialysis was 73% (342 of 469). In-hospital mortality for patients with ventilation by age ranged from 28% (117 of 422) in patients aged 18-59 years to 72% (280 of 388) in patients aged 80 years or older.

INTERPRETATION: In the German health-care system, in which hospital capacities have not been overwhelmed by the COVID-19 pandemic, mortality has been high for patients receiving mechanical ventilation, particularly for patients aged 80 years or older and those requiring dialysis, and has been considerably lower for patients younger than 60 years.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

参考来源

  1. Karagiannidis C, Mostert C, Hentschker C, et al. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med. 2020. PMID: 32735842. doi:10.1016/S2213-2600(20)30316-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。